The goal of gene therapy for patients with hemophilia A is to safely impart long-term stable factor VIII expression that predictably ameliorates bleeding with the use of the lowest possible vector ...
Expression was determined using a validated immunohistochemistry (IHC) assay, 17 categorized on the basis of numerical scores, and then divided into equally sized quartiles. Interaction between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback